Publications by authors named "K D Combrink"

Claim this Profile
C
C25-modified rifamycin derivatives with improved activity against .
Laura Paulowski, Katherine S H Beckham, Matt D Johansen, Laura Berneking, Nhi Van, Keith Combrink

PNAS Nexus· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifamycin derivatives active against pathogenic rapidly-growing mycobacteria.
Keith D Combrink, Andrea Ramirez Ramos, Stephanie Spring, Sebastian Schmidl, Kira Elizondo

Bioorg Med Chem Lett· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design and optimization of potent inhibitors of the adenoviral protease.
Philipp Grosche, Finton Sirockin, Aengus Mac Sweeney, Paul Ramage, Paul Erbel, Keith D Combrink

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure-based optimization of adenain inhibitors.
Aengus Mac Sweeney, Philipp Grosche, David Ellis, Keith Combrink, Paul Erbel

ACS Med Chem Lett· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo optimization of 2,3-diaminopyrazine Rho Kinase inhibitors for the treatment of glaucoma.
Hwang-Hsing Chen, Abdelmoulah Namil, Bryon Severns, Jennifer Ward, Curtis Kelly, Keith D Combrink

Bioorg Med Chem Lett· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis